T-Select HLA-A*24:02 hTERT Tetramer-VYGFVRACL

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Target: Cancer

Product Type: Tetramer

Application: FCM

Conjugate: PE

Class: Class I

Species Reactivity: Human

Allele: HLA-A*24:02

Peptide Sequence: VYGFVRACL

Research Area: Immunology, Immune Monitoring

Protocols: FCM

Specificity: hTERT

Storage Temperature: 4°C

Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.